The buyout firm owned TeamHealth years ago, eventually taking the physician staffing company public in 2009. It has agreed to be taken private for about $6.1 billion.
The second stage of an FCC auction ended quickly, as telecoms, communications companies and investors bid less than expected.
Industry followers continue to see M&A as a way to fuel a turnaround for the beaten down space, and are now looking for first movers with oil above $50.
Texas hedge fund Q Investments claims Community purposefully concealed costs and inflated Ebitda projections to raise a maximum amount of financing in connection with its spinoff of Quorum.
Concern over the steep premium paid for Tobira has been reflected in the public markets, but followers of Allergan say investors reacted too negatively.
The Canadian monetization and customer service specialist has attracted major investments from both a financial sponsor and an activist firm, which believes suitors would step forward during a sales process.
Shares have barely reacted as the Tennessee-based operator of non-urban hospitals explores potential transactions with sponsors.
The Irish drugmaker isn't likely done making deals, even though it just made two, and it could take a look at Alder Biopharmaceuticals next, analysts believe.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.